These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3038161)
1. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays. Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161 [TBL] [Abstract][Full Text] [Related]
2. Human monoclonal anti-D antibodies. II. The relationship between IgG subclass, Gm allotype and Fc mediated function. Kumpel BM; Wiener E; Urbaniak SJ; Bradley BA Br J Haematol; 1989 Mar; 71(3):415-20. PubMed ID: 2539182 [TBL] [Abstract][Full Text] [Related]
3. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report. Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899 [TBL] [Abstract][Full Text] [Related]
4. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D. Kumpel BM Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501 [TBL] [Abstract][Full Text] [Related]
5. Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories. Kumpel BM Transfus Clin Biol; 1996; 3(6):439-52. PubMed ID: 9018805 [TBL] [Abstract][Full Text] [Related]
6. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267 [TBL] [Abstract][Full Text] [Related]
7. Differences in the characteristics of human monoclonal and polyclonal anti-D as revealed by immunochemical investigations: human monoclonal antibodies share specificities with natural antibodies. Thorpe SJ; Bailey SW; Gooi HC; Thompson KM Transfus Med; 1992 Jun; 2(2):151-7. PubMed ID: 1284979 [TBL] [Abstract][Full Text] [Related]
8. In vivo studies of monoclonal anti-D and the mechanism of immune suppression. Kumpel BM Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904 [TBL] [Abstract][Full Text] [Related]
9. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses. Urbaniak SJ; Greiss MA Br J Haematol; 1980 Nov; 46(3):447-53. PubMed ID: 6778497 [TBL] [Abstract][Full Text] [Related]
10. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions. Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function. Armstrong-Fisher SS; Carter MC; Downing I; Fraser RH; Inglis GE; Allan EK; Mackie A; Prowse CV; Templeton JG; Thorpe SJ; Urbaniak SJ Transfusion; 1999 Sep; 39(9):1005-12. PubMed ID: 10533828 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells. Hadley AG; Kumpel BM Immunology; 1989 Aug; 67(4):550-2. PubMed ID: 2504663 [TBL] [Abstract][Full Text] [Related]
13. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis. Kumpel BM; Leader KA; Merry AH; Hadley AG; Poole GD; Blancher A; Goossens D; Hughes-Jones NC; Bradley BA Eur J Immunol; 1989 Dec; 19(12):2283-8. PubMed ID: 2481589 [TBL] [Abstract][Full Text] [Related]
15. Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages. Wiener E; Atwal A; Thompson KM; Melamed MD; Gorick B; Hughes-Jones NC Immunology; 1987 Nov; 62(3):401-4. PubMed ID: 3117677 [TBL] [Abstract][Full Text] [Related]
16. Functional (ADCC) study of 54 IgG MAb anti-RhD. Brossard Y; Dangu C; Patereau C; Goossens D Transfus Clin Biol; 1996; 3(6):459-63. PubMed ID: 9018807 [No Abstract] [Full Text] [Related]
17. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers. Kumpel BM; Goodrick MJ; Pamphilon DH; Fraser ID; Poole GD; Morse C; Standen GR; Chapman GE; Thomas DP; Anstee DJ Blood; 1995 Sep; 86(5):1701-9. PubMed ID: 7655002 [TBL] [Abstract][Full Text] [Related]
19. Idiotypic specificity of a human monoclonal anti-Rhesus(D) antibody. Lambin P; Rouger P; Goossens D; Hérance N; de Saint Martin J; Fine JM; Salmon C Ann Inst Pasteur Immunol; 1986; 137D(3):383-90. PubMed ID: 3030361 [TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity. Sunada M; Suzuki S; Ota Z Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]